§ 10-16-1414. Reports
Notwithstanding section 24-1-136 (11)(a), on or before July 1, 2023, and on or before July 1 each year thereafter, the board shall submit a report to the governor, the health and insurance committee of the house of representatives, and the health and human services committee of the senate, or to any successor committees, summarizing the […]
§ 10-16-1312. Rules
The commissioner may promulgate rules as necessary to develop, implement, and operate this part 13, including rules necessary to align state law with any federal program requirements and applicable rules. Source: L. 2021: Entire part added, (HB 21-1232), ch. 241, p. 1293, § 1, effective June 16.
§ 10-16-1415. Exemption – Prescription Drugs Derived From Cannabis
Notwithstanding any provision of this part 14 to the contrary, the board has no authority to perform an affordability review of, or to establish an upper payment limit for, any prescription drug that is derived in whole or in part from cannabis. Source: L. 2021: Entire part added, (SB 21-175), ch. 240, p. 1276, § […]
§ 10-16-1313. Severability
If any provision of this part 13 or application thereof to any person or circumstances is judged invalid, the invalidity does not affect provisions or applications of this part 13 that can be given effect without the invalid provision or application, and to this end the provisions of this part 13 are declared severable. Source: […]
§ 10-16-1416. Repeal of Part
This part 14 is repealed, effective September 1, 2026. Before the repeal, the functions of the board are scheduled for review in accordance with section 24-34-104. Source: L. 2021: Entire part added, (SB 21-175), ch. 240, p. 1276, § 2, effective June 16.
§ 10-16-1401. Definitions
As used in this part 14, unless the context otherwise requires: “Advisory council” means the Colorado prescription drug affordability advisory council created in section 10-16-1409. “Affordability review” means an affordability review of a prescription drug performed by the board pursuant to section 10-16-1406. “All-payer health claims database” means the all-payer health claims database described in […]
§ 10-16-1402. Colorado Prescription Drug Affordability Review Board – Created – Membership – Terms – Conflicts of Interest
The Colorado prescription drug affordability review board is created in the division. The board is a body politic and corporate and is an instrumentality of the state. The board is an independent unit of state government, and the exercise by the board of its authority under this part 14 is an essential public function. The […]
§ 10-16-1403. Colorado Prescription Drug Affordability Review Board – Powers and Duties – Rules
To protect Colorado consumers from excessive prescription drug costs, the board shall: Collect and evaluate information concerning the cost of prescription drugs sold to Colorado consumers, as described in section 10-16-1405; Perform affordability reviews of prescription drugs, as described in section 10-16-1406; Establish upper payment limits for prescription drugs, as described in section 10-16-1407; and […]
§ 10-16-1404. Colorado Prescription Drug Affordability Review Board Meetings – Required to Be Public – Exceptions
The board shall hold its first meeting within six weeks after all of the board members are appointed and shall meet at least every six weeks thereafter to review prescription drugs; except that the chair may cancel or postpone a meeting if the board has no prescription drugs to review. The board is a state […]
§ 10-16-1405. Colorado Prescription Drug Affordability Review Board – Reports From Carriers and Pharmacy Benefit Management Firms Required – Confidential Materials
Beginning in the 2022 calendar year, for all prescription drugs dispensed at a pharmacy in this state and paid for by a carrier pursuant to a health benefit plan issued under part 2, 3, or 4 of this article 16 during the immediately preceding calendar year, including brand-name drugs, authorized generic drugs, biological products, and […]